Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis
Public ClinicalTrials.gov record NCT03897075. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Assess the Efficacy and Safety of Tildrakizumab in the Treatment of Moderate to Severe Nail Psoriasis
Study identification
- NCT ID
- NCT03897075
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sun Pharmaceutical Industries Limited
- Industry
- Enrollment
- 99 participants
Conditions and interventions
Interventions
- Placebo Drug
- Tildrakizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 12, 2021
- Primary completion
- Apr 4, 2024
- Completion
- Jan 29, 2025
- Last update posted
- Mar 31, 2026
2021 – 2025
United States locations
- U.S. sites
- 11
- U.S. states
- 5
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Dermatology & CRI (Site 18) | Encinitas | California | 92007 | — |
| First OC Dermatology (Site 07) | Fountain Valley | California | 92708 | — |
| Dermatology Research Associates (Site 09) | Los Angeles | California | 90045 | — |
| Clinical Science Institute (Site 14) | Santa Monica | California | 90404 | — |
| Florida Academic Centers Research and Education, LLC (Site 21) | Coral Gables | Florida | 33134 | — |
| Renstar Medical Research (Site 23) | Ocala | Florida | 34470 | — |
| Forest Hills Dermatology Group (Site 04) | Forest Hills | New York | 11375 | — |
| Clinical Partners, LLC (Site 08) | Johnston | Rhode Island | 02919 | — |
| Center for Clinical Studies Cypress (Site 17) | Cypress | Texas | 77433 | — |
| Center for Clinical Studies (Site 11) | Houston | Texas | 77004 | — |
| Progressive Clinical Research (Site 27) | San Antonio | Texas | 78213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03897075, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 31, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03897075 live on ClinicalTrials.gov.